{"id":1086211,"title":"DSEN Abstract: Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-17","captureTimestamp":"2026-04-17T21:37:12.452000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53213.html","snippet":"DSEN Abstract Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure Despite low rates of sofosbuvir failure in the pivotal clinical trials (2 - 4%), this real-world trial shows a higher failure rate of 9.5%. This study also found that patients…","rawSnapshotUrl":"/api/snapshots/raw/1086211","browseUrl":"https://replay.healtharchive.ca/job-8/20260417213712/https://cihr-irsc.gc.ca/e/53213.html#ha_snapshot=1086211","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}